2026 NPPES data Corneal and Contact Management Optometrist NPI 1649300724 O.D.
Verify on CMS →

LENWARD MCCALLA, O.D.

Corneal and Contact Management Optometrist in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
140
Medicare Part D claims · 24 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

LENWARD MCCALLA, O.D. filed 140 Medicare Part D claims in 2023 as a Corneal and Contact Management Optometrist in MIAMI, Florida, prescribing 49% generic.

140
Part D claims, 2023
49%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LENWARD MCCALLA, O.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

140 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about LENWARD MCCALLA, O.D.?

Quality data not reported

NPI registry status

Active

Issued 03/06/2007

NPI 1649300724

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

140 40% vs specialty avg

2023 prescription claims

Specialty avg: 235

Specialty distribution in Florida

How Corneal and Contact Management Optometrist compares to other specialties among Florida providers

Florida providers

Corneal and Contact Management Optometrist share within Florida

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Corneal and Contact Management Optometrist ABMS/AOA estimate

Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LENWARD MCCALLA, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 11417 S DIXIE HWY, MIAMI, FL, 33156, with a listed phone of (305) 378-1915. NPI 1649300724 was issued on 03/06/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCCALLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 140 prescription claims written by this provider, covering 24 Medicare beneficiaries and totaling roughly $32K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11417 S DIXIE HWY
MIAMI, FL 33156

Provider Details

NPI 1649300724
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Male
NPI Issued 03/06/2007

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to LENWARD MCCALLA, O.D.. To verify LENWARD MCCALLA, O.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

LENWARD MCCALLA, O.D. — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 140 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

140
Total Claims
$32K
Total Drug Cost
24
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
195
Total Day Supply
5,385
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$29K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
76.6 years
Avg HCC Risk Score
1.23
Gender Split
50% female / 50% male
Age Distribution
<65: 0, 65-74: 12, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LENWARD MCCALLA, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
51
Timolol Maleate
14
Xiidra
Lifitegrast
14
Dorzolamide Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How LENWARD MCCALLA, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

LENWARD MCCALLA, O.D.'s 140 claims are below the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as MCCALLA.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LENWARD MCCALLA, O.D.'s specialty?
LENWARD MCCALLA, O.D. specializes in Corneal and Contact Management Optometrist and practices in MIAMI, Florida. Credentials: O.D..
How much does LENWARD MCCALLA, O.D. prescribe under Medicare Part D?
In 2023, LENWARD MCCALLA, O.D. wrote 140 Medicare Part D claims totaling $32K in drug costs for 24 beneficiaries.
Where is LENWARD MCCALLA, O.D. located?
LENWARD MCCALLA, O.D. is located at 11417 S DIXIE HWY, MIAMI, FL, 33156. Phone: (305) 378-1915.
What is LENWARD MCCALLA, O.D.'s NPI number?
LENWARD MCCALLA, O.D.'s National Provider Identifier (NPI) is 1649300724, issued on 03/06/2007.
Does LENWARD MCCALLA, O.D. prescribe more brand-name or generic drugs?
LENWARD MCCALLA, O.D.'s prescribing is 51% brand-name and 49% generic drugs by claim count, with $29K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does LENWARD MCCALLA, O.D. prescribe most often?
Based on 2023 Medicare Part D data, LENWARD MCCALLA, O.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Xiidra. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LENWARD MCCALLA, O.D. accept Medicare?
LENWARD MCCALLA, O.D. appears in CMS Medicare data with 140 Part D claims and 24 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LENWARD MCCALLA, O.D.'s credentials?
LENWARD MCCALLA, O.D.'s NPI is 1649300724 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology